BRIGHTX

Data Driven. Texas Built.

Phase I–IV clinical development expertise across all therapeutic areas.

BRIGHTX delivers the full range of clinical development services — regulatory strategy, clinical operations, biometrics, pharmacovigilance, medical writing, and clinical supply — backed by Bright Pharmaceutical Services' 20+ years of CRO delivery across pharma, biotech, device, and government clients.

With the Texas presence CPRIT grantees need, and the experienced network of clinical trials veterans that pharma and biotech clients require, BRIGHTX can handle all aspects of your trial, regardless of size — but without the corporate bloat that has larger CROs gatekeeping their project managers behind a wall of industry newbies.

Our Houston headquarters puts us in the heart of Texas's most prestigious medical center ecosystem — the largest in the world. Proximity to MD Anderson, Houston Methodist, UTHealth, and the Texas Medical Center isn't a coincidence. It's the point.

20+

Years of CRO Operations

Backed by Bright Pharmaceutical Services, a full-service CRO founded in 2002 serving pharma, biotech, device, and government clients.

12,000+

Global Investigator Network

Investigators across 6,000+ sites worldwide — curated and performance-tracked over two decades of global trial delivery.

<4.5%

Staff Retention

Turnover year on year since inception. The team that starts your program is the team that finishes it.

Houston, Texas — BRIGHTX headquarters

Houston, Texas — BRIGHTX headquarters

Dedicated project teams

Each program gets a named project manager, clinical operations lead, medical monitor, and data management lead — accessible directly, not through layers of account management.

Your team is with you every step of the way — not just when problems arise. That continuity is why sponsors come back for their next program.

Deep oncology bench

The team you start with is the team you finish with — not staff that was trained last week and handed your program.

When your CMO has questions about basket trial design or CAR-T monitoring requirements, they're talking to someone who has run those studies.

Capabilities

Full-service CRO. Every function, in-house.

Regulatory, clinical operations, biometrics, safety, and supply — all delivered by teams with the track record to back it up. Built on Bright Pharmaceutical Services' operational playbooks, refined across hundreds of global studies since 2002, spanning Phase I–III programs, complex indications, and full-service execution.

Global Clinical Development

Phase I–IV trial management across 50+ countries, with a risk-based monitoring model that keeps oversight tight without inflating site costs. Hybrid and decentralized trial models are standard — not an add-on.

Phase I–IVRisk-Based MonitoringSite NetworkDecentralized

Regulatory & Quality

IND, CTA, and IDE filings with FDA, EMA, Health Canada, and PMDA. Our regulatory team prepares Type A/B/C meeting packages, handles eCTD publishing in-house, and maintains a QMS built on ICH-GCP and ICH Q10 frameworks.

IND / CTA / IDEAgency MeetingseCTDInspection Readiness

Biometrics & Data Sciences

Statistical programming, data management, and biostatistics delivered by an experienced, dedicated team. CDISC standards (SDTM, ADaM), submission-ready datasets, and MedDRA / WHO Drug coding — delivered by a team that has done this for FDA and EMA submissions.

SDTM / ADaMSAP DevelopmentMedical CodingSubmission-Ready

Safety & Pharmacovigilance

24/7 case processing, CIOMS-I and MedWatch reporting, DSURs, IND annual reports, and signal detection on a rolling surveillance schedule.

Case ProcessingSignal DetectionDSUR / IND Annual Report

Get in touch

Ready to discuss your program?

Whether you're scoping a new Phase I or managing an existing CPRIT award, a program lead is ready to talk through what BRIGHTX can offer.